Skip to main content
. 2017 May 30;17:373. doi: 10.1186/s12879-017-2473-y

Table 3.

Causes of death after TB treatment initiation, n = 310, INI-Fiocruz cohort, 2000–2010

Underlying cause of death; n (%) Immediate cause of death; n (%) Contributing cause of deatha; n
≤ 90 days
N = 21
> 90 days
N = 43
≤ 90 days
N = 21
> 90 days
N = 43
≤ 90 days > 90 days
Aids 18 (85.72) 30 (69.80) Invasive bacterial disease 11 (52.38) 19 (44.20) Tuberculosis 12 15
Invasive bacterial disease 1 (4.76) 1 (2.30) Aids 4 (19.04) 6 (14.00) Aids 9 18
Renal failure 0 2 (4.70) Tuberculosis 3 (14.30) 6 (14.00) Invasive bacterial disease 4 2
Hepatic cirrhosis 1 (4.76) 0 Acute coronary disease 0 1 (2.30) IRIS 1 2
Hepatitis C, chronic 1 (2.30) Heart failure 0 1 (2.30) Renal failure 1 1
Heart failure 0 1 (2.30) Renal failure 0 1 (2.30) Hepatotoxicity 0 1
Acute coronary disease 0 1 (2.30) Hepatic failure 1 (4.76) 0 Hepatic failure 0 2
Chronic obstructive pulmonary disease (COPD) 1 (2.30) Acute respiratory distress 0 1 (2.30) Hepatitis B, chronic 0 1
Depression 0 1 (2.30) Lactic acidosis 0 1 (2.30) Others 4 15
Violent death 0 2 (4.70) Suicide 0 1 (2.30)
Drug abuse 1 (2.30) Violent death 0 1 (2.30)
Unknown 1 (4.76) 2 (4.70) Head trauma 0 1 (2.30)
Digestive hemorrhage 1 (4.76) 0
Unknown 1 (4.76) 4 (9.4)

aMore than one contributing cause of death can be reported.

IRIS: immune reconstitution inflammatory syndrome.